Profile picture

Assistant Professor Veronika Shishkova

National Research Center for Therapy and Preventive Medicine, Moscow (Russian Federation)
Follow
Logo ESC

Contributor content

Haplotype analysis of polymorphic genes of lipid metabolism and its association with an increased risk of the first non-cardioembolic ischemic stroke
Presentation
Haplotype analysis of polymorphic genes of lipid metabolism and its association with an increased risk of the first non-cardioembolic ischemic stroke
Assessment of  of twenty-five variants of polymorphic genes for lipid and carbohydrate metabolism, vascular inflammation and the neurotransmitter system in the first non-cardioembolic ischemic stroke
Presentation
Assessment of of twenty-five variants of polymorphic genes for lipid and carbohydrate metabolism, vascular inflammation and the neurotransmitter system in the first non-cardioembolic ischemic stroke
Prognostic model of the development of the first atherothrombotic stroke
Presentation
Prognostic model of the development of the first atherothrombotic stroke
Prognostic significance of clinical-anthropometric, biochemical, metabolic, vascular-inflammatory and molecular-genetic markers in the development of the first ischemic stroke.
Presentation
Prognostic significance of clinical-anthropometric, biochemical, metabolic, vascular-inflammatory and molecular-genetic markers in the development of the first ischemic stroke.
Predictors of recurrent stroke
Presentation
Predictors of recurrent stroke
Assessment of the polymorphic genes variants of the lipid and carbohydrate metabolism, vascular inflammation and neurotransmitter system in the first ischemic stroke
Presentation
Assessment of the polymorphic genes variants of the lipid and carbohydrate metabolism, vascular inflammation and neurotransmitter system in the first ischemic stroke
Prognostic significance of clinical-anthropometric, biochemical, metabolic, vascular-inflammatory and molecular-genetic markers in the development of the first ischemic stroke.
Presentation
Prognostic significance of clinical-anthropometric, biochemical, metabolic, vascular-inflammatory and molecular-genetic markers in the development of the first ischemic stroke.

ESC 365 is supported by